The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study

Erzincan Binali Yildirim Universitesi60 enrolled

Overview

This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.

Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Hemodialysis Color Therapy

Interventions

Color therapyOTHER

In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.

Eligibility

Sex: ALLMin age: 18 Weeks

Medical Language ↔ Plain English

Inclusion Criteria: * Be on hemodialysis treatment for at least 6 months, * No sleeping pills or sedative medication, * No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness, * The patient or someone living in the same household with the patient is literate, * Patients have no vision problems, * Patients must be 18 years of age or older. Exclusion Criteria: * Being on hemodialysis treatment for less than 6 months, * Taking sleeping pills or sedative medication, * Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided, * Illiteracy of the patient and relatives, * Patients have vision problems, * Refusing to participate in the research, * Under 18 years of age

Locations (1)

Fırat University

Elâzığ, Merkez, Turkey (Türkiye)

Outcomes

Primary Outcomes

Depression Anxiety Stress-21 scale (DASS-21)

The 21-question DASS scale used in the study was taken by Henry and Crawford. This scale (DASS-21) has 7 questions each to measure the dimensions of depression, stress and anxiety. The scale is a 4-point Likert-type scale, coded as 0 "not applicable to me", 1 "somewhat applicable to me", 2 "generally applicable to me", and 3 "completely applicable to me".

Time frame: 8 week

Short Form-12 (SF-12) Quality of Life Scale

Ware et al. decided to develop a more practical form of the SF-36 that could be administered in a shorter time and developed the SF-12, which contains the same sub-dimensions as the SF-36 by reducing the number of questions. In addition to the fact that the SF-12 was created in such a way that the same component summary scores can be obtained as the SF-36, the fact that it contains fewer items and therefore has a shorter administration time provides a great advantage. Although it has been demonstrated that the SF-36 scale has sufficient validity and reliability in studies conducted in both patient and normal sample groups in our country, the validity and reliability study of the Turkish form of the SF-12, which was developed as a shorter alternative to the SF-36, was attempted. Similar to SF-36, SF-12 consists of 8 sub-dimensions and 12 items including physical functioning (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social function

Time frame: 8 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.